Search research articles
Contact Us
Filters
Showing results (161-170 of 196) with videos related to
Page
of 20
Sort By:
British Journal of Cancer
|
November 1, 1986
Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow
K Ono, C Komuro, K Tsutsui, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 27, 1999
External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection
B Jeremic, Y Shibamoto, B Milicic, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1999
Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial
B Jeremic, Y Shibamoto, B Milicic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2000
A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer
B Jeremic, Y Shibamoto, B Milicic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain
V T Kagiya, T Sugita, S Nishimoto, et al.
Surgical Neurology
|
October 1, 1990
Intracerebral malignant lymphoma with fluctuating regression and spatial evolution
T Yamasaki, H Kikuchi, J Yamashita, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 30, 1995
Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity
N Oya, Y Shibamoto, K Sasai, et al.
Acta Neurochirurgica. Supplement
|
February 14, 2012
Delta-ADC (apparent diffusion coefficient) analysis in patients with idiopathic normal pressure hydrocephalus
T Osawa, M Mase, T Miyati, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics
K Sasai, Y Shibamoto, M Takahashi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation
K Sasai, M Fushiki, Y Yukawa, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 196) with videos related to
Sort By:
Page
of 20
British Journal of Cancer
|
November 1, 1986
Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow
K Ono, C Komuro, K Tsutsui, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 27, 1999
External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection
B Jeremic, Y Shibamoto, B Milicic, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1999
Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial
B Jeremic, Y Shibamoto, B Milicic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2000
A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer
B Jeremic, Y Shibamoto, B Milicic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain
V T Kagiya, T Sugita, S Nishimoto, et al.
Surgical Neurology
|
October 1, 1990
Intracerebral malignant lymphoma with fluctuating regression and spatial evolution
T Yamasaki, H Kikuchi, J Yamashita, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 30, 1995
Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity
N Oya, Y Shibamoto, K Sasai, et al.
Acta Neurochirurgica. Supplement
|
February 14, 2012
Delta-ADC (apparent diffusion coefficient) analysis in patients with idiopathic normal pressure hydrocephalus
T Osawa, M Mase, T Miyati, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics
K Sasai, Y Shibamoto, M Takahashi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation
K Sasai, M Fushiki, Y Yukawa, et al.
Page
of 20